Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × trastuzumab deruxtecan × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 51 Neoplasm Metastasis 20 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 8 Brain Neoplasms 8 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Salivary Gland Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms 3 Adenocarcinoma 3 Prostatic Neoplasms 2 Meningeal Carcinomatosis 2 HER2-positive Gastric Cancer 2 Esophageal Neoplasms 2 Breast Cancer With Brain Metastasis 2 Advanced Breast Cancer 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Solid Cancer 1 Small Cell Lung Carcinoma 1

Interventions

Bevacizumab 59 atezolizumab 51 durvalumab 37 lenvatinib 35 pembrolizumab 33 Nivolumab 28 tremelimumab 23 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Sorafenib 16 Ipilimumab 13 tislelizumab 12 regorafenib 12 cabozantinib 12 apatinib 11 Radiosurgery 11 Immune Checkpoint Inhibitors 11 sintilimab 10 camrelizumab 9 Blood Specimen Collection 9 Radiotherapy 8 Immunoglobulin G 7 Cyclophosphamide 7 X-Rays 6 Hepatectomy 6 Disulfides 6 donafenib 5 Surgical Procedures, Operative 5 Fluorouracil 5 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡